This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 26 Nov 2021  |  Europe

    EU COVID-19 Vaccine and Therapeutics Insights, Trends, and Growth Opportunities

    Future Growth Potential Driven by Capabilities and Expertise in Vaccine Manufacturing

    With this research service, Frost & Sullivan’s Healthcare and Life Sciences team provides critical insights into the European Union and UK COVID-19 vaccine and therapeutics market. The report analyzes COVID-19 vaccines and therapeutics in development and delves into supply chain considerations and requirements to manage distribution. Importantly,...

    $2,450.00
  2. 22 Mar 2021  |  Europe

    Impact of COVID-19 on Elective Procedures in Western Europe, 2020–2023

    Growth Strategies to Navigate the Uncertainty Surrounding Elective Procedure Deferrals and Their Impact on the Medical Device Market

    The deferral of elective procedures due to pandemic-related measures has adversely affected the cardiovascular medical devices market. While some cardiovascular procedures are considered urgent, others have been rescheduled and deferred. Nearly 80% of all the orthopedic procedures performed in Europe are estimated to have been delayed, postponed,...

    $4,950.00
  3. 11 Feb 2021  |  Europe

    Innovative Business Models Powering the Telehealth Market in Europe

    Expansion in Consumer Health and Improved Access to Care Spur New Growth Opportunities

    As the rapid spread and impact of COVID-19 continue to cripple healthcare sector providers across Europe, telehealth is emerging as a boon in ensuring efficient access to essential healthcare services. Primary care appointments took a major downturn as people avoided them largely until necessary or were unable to have routine face-to-face visits du...

    $4,950.00
  4. 30 Dec 2016  |  Europe

    Israeli Technologies Impacting the Global Medical Sector

    Gaining efficiency in commercial ventures in global medical devices industry by effectively collaborating with key innovation stakeholders in Israel

    Over the past two decades, Israel had risen to be an global medical devices innovation hub, reinforcing its position as one of the major contributors to the growth of the innovations in the global medical devices sector. With a plethora of scientific resources, ease of conducting clinical research studies, globally competitive intellectual portfoli...

    $4,950.00
  5. 20 Dec 2016  |  Europe

    Market Analysis of Emerging Cardiac Therapies in the United States and Western Europe, Forecast to 2020

    With Double Digit Growth Rates and Strong Product Pipeline, the Emerging Cardiac Devices Market will Witness a Transformation in the Next 5 Years

    The biggest challenge for emerging cardiac procedures is adoption barrier and reimbursement. The long-term clinical evidence gathered through clinical studies and the technological improvement in the product pipeline has addressed the adoption barrier and reimbursement coverage based on morbidity of the patients is the first step towards increased ...

    $4,950.00
  6. 28 Nov 2016  |  Europe

    Western Europe Hospital Information Technology Outlook, 2016–2020

    Growth Opportunities in Health Informatics will Drive Digital Health Transformation Strategies in the Multibillion-dollar Hospital IT Market

    This study aims to analyse and forecast the Western European Hospital Information Technology (IT) market outlook for 2016–2020. Western European hospital IT market is expected to reach a revenue of $10.72 billion in 2020, growing at a CAGR of over 5.1% from 2016 to 2020. Research Scope • This research analyses various healthcare in...

    $4,950.00
  7. 15 Jul 2016  |  Europe

    Snapshot of the Mobile Health (mHealth) Market Opportunity in Europe

    Sector Convergence is Generating Growth Opportunities Across the Value Chain

    Mobile Health (mHealth) can play a vital role in European healthcare systems by improving communication between providers and patients and enabling patients to participate more actively in their health and wellness. At both EU and country levels, various pilot projects have demonstrated positive outcomes—both qualitative and quantitative—result...

    $1,500.00
  8. The Serbian surgical devices distribution market encompasses wound closure devices, such as sutures, staples, energy devices, and tissue sealants and haemostats. The data presented in this study is based on both primary (interviews with manufacturers, distributors, and surgeons) and secondary research. This study analyses key competitive landscape,...

    $3,000.00
  9. 01 Jul 2016  |  Europe

    Western Europe Point-of-Care Testing (POCT) Market

    Point-of-care testing is an integral part of the IVD market that is rapidly evolving into a preferred testing mode in the EU region. POCT is a segment that presents growth opportunities for a cross-section of players, ranging from OEMs to data integrators to technology vendors. The stakeholders need to be abreast of the challenges posed by the indu...

    $4,950.00
  10. 24 Jun 2016  |  Europe

    Business Analytics in Life Sciences

    The Time is Ripe for a Technology Revamp in Clinical Trials

    The drastic increase in the number of clinical trials performed worldwide is leading to a sharp rise in R&D expenditure incurred by life sciences companies. To overcome this challenge, companies are targeting clinical trials to achieve higher efficiencies, which will bring new drugs faster to market and reduce R&D cost burden. The solution lies in ...

    $3,000.00